市場調査レポート
商品コード
1039478

除細動器の世界市場 (~2026年):製品タイプ (植込み型除細動器・体外式除細動器)・患者区分 (成人・小児)・エンドユーザー・地域別

Defibrillator Market by Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Pediatric), End Users, and Region(North America, Europe, APAC, Latin America & MEA) - Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 219 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.89円
除細動器の世界市場 (~2026年):製品タイプ (植込み型除細動器・体外式除細動器)・患者区分 (成人・小児)・エンドユーザー・地域別
出版日: 2021年11月25日
発行: MarketsandMarkets
ページ情報: 英文 219 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の除細動器の市場規模は、2021年の114億米ドルから、2026年には182億米ドルに達し、予測期間中は9.7%のCAGRで成長すると予測されています。

対象となる疾患の増加、公共の場での除細動器の提供、除細動器に関するトレーニングや啓蒙活動などの要因が同市場の成長を推進しています。さらに、新興市場の存在や、皮下植込み型除細動器 (S-ICD) や、MRI対応の植込み型除細動器 (ICD) や両室ペーシング機能付き植込み型除細動器 (CRT-D) の開発などが参入事業者に成長機会を示すと予測されています。

製品タイプ別で見ると、植込み型除細動器 (ICD) の部門が2020年に71.5%で最大のシェアを示しています。心血管疾患の有病率の増加、技術的に高度な除細動器の開発などの要因が大規模シェア獲得の要因となっています。

当レポートでは、世界の除細動器の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制・償還環境、特許動向、市場規模の推移・予測、タイプ・患者区分・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 推進要因
    • 阻害要因
    • 市場機会
    • 課題
  • 産業動向
  • 価格分析
  • 規制分析
  • バリューチェーン分析
  • エコシステム
  • 償還シナリオ
  • ポーターのファイブフォース分析
  • COVID-19の影響
  • 特許分析

第6章 除細動器市場:タイプ別

  • 植込み型除細動器 (ICD)
    • 経静脈植込み型除細動器 (TV-ICD)
    • 皮下植込み型除細動器 (S-ICD)
  • 体外式除細動器
    • 手動・半自動体外式除細動器
    • 全自動体外式除細動器
    • 着用型心臓除細動器

第7章 除細動器市場:患者区分別

  • 成人
  • 小児

第8章 除細動器市場:エンドユーザー別

  • 病院・診療所・心臓病センター
  • プレホスピタルケア
  • パブリックアクセス
  • 代替ケア
  • 在宅ケア
  • その他

第9章 除細動器市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合環境

  • 収益シェア分析
  • 市場シェア分析
  • 競合リーダーシップマッピング:企業評価クアドラント
  • 競合リーダーシップマッピング:新興・中小企業評価クアドラント
  • 競合ベンチマーキング
  • 競合シナリオ

第11章 企業概要

  • 主要企業
    • MEDTRONIC
    • STRYKER CORPORATION
    • KONINKLIJKE PHILIPS N.V.
    • ASAHI KASEI CORPORATION
    • BOSTON SCIENTIFIC CORPORATION
    • ABBOTT
    • MICROPORT
    • NIHON KOHDEN CORPORATION
    • BIOTRONIK
    • CU MEDICAL SYSTEMS INC.
    • METSIS MEDIKAL
    • MEDIANA CO. LTD.
    • MINDRAY MEDICAL INTERNATIONAL LIMITED
    • PROGETTI SRL-MEDICAL EQUIPMENT SOLUTIONS
    • SCHILLER AG
  • その他の企業
    • BPL MEDICAL TECHNOLOGIES
    • METRAX GMBH(PRIMEDIC)
    • MS WESTFALIA GMBH
    • BEXEN CARDIO
    • AXION MEDICAL EQUIPMENT LTD.
    • ELEMENT SCIENCE INC.
    • AVIVE SOLUTIONS INC.
    • JEEVTRONICS PVT. LTD.
    • HEARTHERO INC.
    • SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.

第12章 付録

目次
Product Code: MD 3124

The global defibrillator market is expected to reach USD 18.2 billion by 2026 from an estimated USD 11.4 billion in 2021, at a CAGR of 9.7% from 2021 to 2026.

Defibrillators are specialized devices that monitor the heart rhythm and deliver electric shocks to rectify abnormal heart rhythms on detection, and as such, play an important role in the treatment of sudden cardiac arrest. Growth in this market is mainly driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. In addition, emerging markets and the development of S-ICDs and MRI-compatible ICDs and CRT-Ds are expected to offer growth opportunities for players in the defibrillators market. Cardiovascular disease (CVD) is a leading cause of death and disability across the globe. Globally, 17.9 million deaths due to CVD were reported in 2019, which amounts to 32% of the total deaths worldwide (Source: WHO). More than 75% of deaths due to CVDs occur in low- and middle-income countries. In the US alone, there were more than 390,000 sudden cardiac arrests in 2018 (Source: American Heart Association). Of the total US population, around 65% of deaths due to CVDs occur in people aged 75 and over, 29% in the age group of 55-74, and 6% in the age group of 35-54. Owing to this, the demand for defibrillators has increased, as these devices help save the lives of patients at a high risk of cardiac arrest.

However, issues related to the use of implantable and automated external defibrillators, frequent product recalls, and a lack of awareness about sudden cardiac arrest in developing nations are expected to hinder the growth of the defibrillators market during the forecast period. Other factors such as limited reimbursements, lack of infrastructure, particularly in developing and underdeveloped countries are also expected to hinder the growth of this market.

"Implantable Cardioverter Defibrillator segment accounted for the largest share of global defibrillator market in 2020"

Based on type, the defibrillators market is broadly segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs is further divided into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators, whereas external defibrillators are divided into manual aed, fully automated aed and wearable defibrillator. The ICDs segment accounted for a share of 71.5% of the global defibrillators market in 2020. The large share of this market segment can be attributed to the increasing prevalence of cardiovascular diseases and the development of technologically advanced defibrillators. For instance in July 2020, Abbott received FDA approval for its next-generation ICDs and CRT-Ds under the brand name of Gallant.

"Hospitals, clinics and cardiac centres segment accounted for the largest market share of the defibrillator market based on end user in 2020"

Based on end users, the defibrillators market is segmented into hospitals, clinics, and cardiac centers; prehospital care settings; public-access markets; alternate care facilities; home care settings; and other end users. The hospitals, clinics, and cardiac centers segment dominated the global defibrillators market, with a share of 80.2%, in 2020. The development of advanced ICDs and CRT-Ds and the large number of ICD and CRT-D implant procedures performed in hospitals, clinics, and cardiac centers are the major factors contributing to the large share of this end-user segment. The growing number of cardiac implant procedures and the availability of reimbursements across developed markets are the other major factors driving the growth of this end-user segment. According to the American Heart Association, an estimated 10,000 ICD procedures are carried out each month in the US alone (data as of July 2016). Similarly, the total number of ICD implants in England increased to 72 per million population in 2014 from 66 per million population in 2012 (Source: British Heart Rhythm Society).

"Adult patients segment accounted for the largest market share of the defibrillator market based on patients type in 2020"

Based on patient type, the defibrillators market is segmented into adult and pediatric patients. The adult patients segment dominated the global defibrillators market with a share of 59.5% in 2020.

In 2020, there were roughly 75 million adult patients (in the age group of 15 years and over) globally and 25 million pediatric patients (in the age group of 0-14 years) (Source: World Bank). According to data by the World Health Organization (WHO), around 30% of all global deaths occur due to cardiovascular disease, accounting for 17.9 million lives lost each year. About 2 in 10 deaths due to CVD (cardiovascular disease) occur in patients aged less than 65 (Source: Center for Disease Control and Prevention). The major reasons for heart disease are high blood pressure, high cholesterol, diabetes, obesity, unhealthy diets, physical inactivity, and excessive alcohol use.

The development of advanced ICDs, CRT-Ds, and AEDs, along with increasing awareness about cardiac diseases and preventive measures taken by government bodies, are the major factors contributing to the growth of the market.

"The APAC market, by region, to register highest growth rate in the forecast period"

The global defibrillators market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 44.2% of the global defibrillators market, followed by Europe. On the other hand, the Asia Pacific market is estimated to register the highest growth rate during the forecast period. Factors such as the high burden of target diseases, rising geriatric population, and increasing awareness regarding defibrillators support the growth of the defibrillators market in the APAC. Particularly in Japan; increasing disposable incomes, allowing for greater affordability for advanced technologies; the rising prevalence of target diseases; and favorable government initiatives. Such factors help to drive the market in this region and draw foreign investments and partnerships. On the other hand, low hospital budgets, high equipment costs, and a lack of government investments in some countries are limiting the growth of the market in the Asia Pacific to a certain extent.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-25%, Tier 2-37%, and Tier 3- 38%
  • By Designation: C-level-34%, Director-level-35%, and Others-31%
  • By Region: North America-24%, Europe-32%, Asia Pacific-28%, Latin America-10%, and the Middle East & Africa-6%

Prominent players in the defibrillators market include Medtronic (Ireland), Stryker Corporation (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), Nihon Kohden (Japan) and MicroPort (China).

Research Coverage

This report studies the defibrillator market based on product type, patient type, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the defibrillaotr market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the defibrillator market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the defibrillator market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 KEY MARKET STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA SOURCES
      • 2.1.1.1 Indicative List of Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION
      • 2.1.2.1 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION METHODOLOGY
    • FIGURE 3 REVENUE MAPPING-BASED MARKET ESTIMATION
    • FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • 2.3 MARKET DATA VALIDATION AND TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION METHODOLOGY
  • 2.4 KEY RESEARCH ASSUMPTIONS
  • 2.5 LIMITATIONS
    • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: DEFIBRILLATORS MARKET
  • 2.7 COVID-19 HEALTH ASSESSMENT
  • 2.8 COVID-19 ECONOMIC ASSESSMENT
  • 2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021-2022)

3 EXECUTIVE SUMMARY

    • FIGURE 8 DEFIBRILLATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 9 DEFIBRILLATORS MARKET SHARE, BY END USER, 2020 VS. 2026
    • FIGURE 10 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021 VS. 2026
    • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE DEFIBRILLATORS MARKET

4 PREMIUM INSIGHTS

  • 4.1 DEFIBRILLATORS MARKET OVERVIEW
    • FIGURE 12 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH
  • 4.2 DEFIBRILLATORS MARKET, BY REGION AND END USER, 2020 (USD MILLION)
    • FIGURE 13 HOSPITALS, CLINICS, AND CARDIAC CENTERS TO DOMINATE THE DEFIBRILLATORS MARKET, BY END USER, IN 2020
  • 4.3 DEFIBRILLATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 IMPLANTABLE DEFIBRILLATORS WILL CONTINUE TO DOMINATE THE DEFIBRILLATORS MARKET IN 2026
  • 4.4 GEOGRAPHIC SNAPSHOT OF THE DEFIBRILLATORS MARKET
    • FIGURE 15 ASIA PACIFIC IS THE FASTEST-GROWING MARKET FOR DEFIBRILLATORS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of target diseases
    • FIGURE 17 GERIATRIC POPULATION, BY REGION, 2019 VS. 2030 (THOUSAND)
      • 5.2.1.2 Growing focus on providing public-access defibrillators
      • 5.2.1.3 Training & awareness programs on defibrillators
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Issues related to the use of implantable and automated external defibrillators
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
      • 5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Frequent product recalls
    • TABLE 2 RECENT PRODUCT RECALLS BY THE US FDA, 2018-2021
      • 5.2.4.2 Lack of awareness about sudden cardiac arrest in developing nations
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 INCREASING PRICING PRESSURE ON MARKET PLAYERS
    • 5.3.2 GROWING NUMBER OF MERGERS & ACQUISITIONS AMONG MARKET PLAYERS
    • 5.3.3 RISING DEMAND FOR AUTOMATED EXTERNAL DEFIBRILLATORS IN PREHOSPITAL SETTINGS
  • 5.4 PRICING ANALYSIS
    • TABLE 3 PRICING ANALYSIS: DEFIBRILLATORS MARKET, 2021 (USD)
  • 5.5 REGULATORY ANALYSIS
    • TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE DEFIBRILLATORS MARKET
    • 5.5.1 NORTH AMERICA
      • 5.5.1.1 US
    • TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY THE US FDA
    • TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.5.1.2 Canada
    • TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.5.2 EUROPE
    • 5.5.3 ASIA PACIFIC
      • 5.5.3.1 Japan
    • TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.5.3.2 China
    • TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.5.3.3 India
  • 5.6 VALUE CHAIN ANALYSIS
    • 5.6.1 RESEARCH & DEVELOPMENT
    • 5.6.2 MANUFACTURING & ASSEMBLY
    • 5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
    • FIGURE 18 DEFIBRILLATORS MARKET: VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM LANDSCAPE
  • 5.8 REIMBURSEMENT SCENARIO
    • TABLE 10 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN THE US 2021
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 11 DEFIBRILLATORS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT FROM NEW ENTRANTS
    • 5.9.2 THREAT FROM SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF SUPPLIERS
    • 5.9.4 BARGAINING POWER OF BUYERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 IMPACT OF COVID-19 ON THE DEFIBRILLATORS MARKET
  • 5.11 PATENT ANALYSIS
    • 5.11.1 PATENTS GRANTED FOR DEFIBRILLATORS
    • FIGURE 19 PATENTS GRANTED FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021)
    • 5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS
    • TABLE 12 TOP 20 PATENT OWNERS FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021)
    • FIGURE 20 TOP 10 PATENT APPLICANTS FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021)
    • FIGURE 21 PATENT DOCUMENTS FOR DEFIBRILLATORS, BY JURISDICTION (JANUARY 2011 TO SEPTEMBER 2021)

6 DEFIBRILLATORS MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 13 DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 14 DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
    • TABLE 15 DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
    • TABLE 16 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
  • 6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    • TABLE 17 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
    • TABLE 19 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
    • TABLE 20 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
    • 6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    • TABLE 21 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 22 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
      • 6.2.1.1 Biventricular ICDs/cardiac resynchronization therapy defibrillators
        • 6.2.1.1.1 Launch of technologically advanced CRT-D devices to support market growth
    • TABLE 23 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
      • 6.2.1.2 Dual-chamber ICDs
        • 6.2.1.2.1 Dual-chamber ICDs reduce the incidence of inappropriate shocks-a key factor driving market growth
    • TABLE 24 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
      • 6.2.1.3 Single-chamber ICDs
        • 6.2.1.3.1 Single-chamber ICDs are associated with the increased risk of inappropriate shocks-a key factor limiting market growth
    • TABLE 25 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
    • 6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
      • 6.2.2.1 S-ICDs segment to register the highest growth in the ICDs market
    • TABLE 26 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
  • 6.3 EXTERNAL DEFIBRILLATORS
    • TABLE 27 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 28 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
    • TABLE 29 EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
    • TABLE 30 EXTERNAL DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
    • 6.3.1 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS
      • 6.3.1.1 Development of technologically advanced AEDs negatively affects the market for manual external defibrillators
    • TABLE 31 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
    • 6.3.2 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS
      • 6.3.2.1 Increasing installation of these devices in public places to drive market growth
    • TABLE 32 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
    • 6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS
      • 6.3.3.1 Concerns associated with the use of WCDs are expected to hamper their adoption
    • TABLE 33 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)

7 DEFIBRILLATORS MARKET, BY PATIENT TYPE

  • 7.1 INTRODUCTION
    • TABLE 34 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
  • 7.2 ADULT PATIENTS
    • 7.2.1 ADVANCEMENTS IN DEFIBRILLATION TECHNIQUES TO BOOST ADOPTION OF DEFIBRILLATORS AMONG ADULT PATIENTS
    • TABLE 35 DEFIBRILLATORS MARKET FOR ADULT PATIENTS, BY REGION, 2018-2026 (USD MILLION)
  • 7.3 PEDIATRIC PATIENTS
    • 7.3.1 INCREASING INCIDENCE OF PEDIATRIC HEART AILMENTS TO DRIVE MARKET GROWTH
    • TABLE 36 DEFIBRILLATORS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2018-2026 (USD MILLION)

8 DEFIBRILLATORS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 37 DEFIBRILLATORS MARKET, BY END USER TYPE, 2018-2026 (USD MILLION)
  • 8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS
    • 8.2.1 MOST ICD PROCEDURES ARE CARRIED OUT IN HOSPITALS, CLINICS, AND CARDIAC CENTERS-A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 38 DEFIBRILLATORS MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2018-2026 (USD MILLION)
  • 8.3 PREHOSPITAL CARE SETTINGS
    • 8.3.1 GROWING FUNDING FOR PREHOSPITAL EMERGENCY AMBULANCE SERVICES IN DEVELOPING COUNTRIES TO SUPPORT MARKET GROWTH
    • TABLE 39 DEFIBRILLATORS MARKET FOR PREHOSPITAL CARE SETTINGS, BY REGION, 2018-2026 (USD MILLION)
  • 8.4 PUBLIC-ACCESS MARKETS
    • 8.4.1 RISING INCIDENCE OF OUT-OF-HOSPITAL CARDIAC ARRESTS TO DRIVE THE ADOPTION OF DEFIBRILLATORS
    • TABLE 40 DEFIBRILLATORS MARKET FOR PUBLIC-ACCESS MARKETS, BY REGION, 2018-2026 (USD MILLION)
  • 8.5 ALTERNATE CARE FACILITIES
    • 8.5.1 UNDERDEVELOPED INFRASTRUCTURE FOR ALTERNATE CARE IN MOST EUROPEAN COUNTRIES AND EMERGING NATIONS TO RESTRAIN MARKET GROWTH
    • TABLE 41 DEFIBRILLATORS MARKET FOR ALTERNATE CARE FACILITIES, BY REGION, 2018-2026 (USD MILLION)
  • 8.6 HOME CARE SETTINGS
    • 8.6.1 INCREASING ADOPTION OF HOME AUTOMATED EXTERNAL DEFIBRILLATORS-A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 42 DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2018-2026 (USD MILLION)
  • 8.7 OTHER END USERS
    • TABLE 43 DEFIBRILLATORS MARKET FOR OTHER END USERS, BY REGION, 2018-2026 (USD MILLION)

9 DEFIBRILLATORS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 22 GEOGRAPHIC SNAPSHOT OF THE DEFIBRILLATORS MARKET
    • TABLE 44 DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 23 NORTH AMERICA: DEFIBRILLATORS MARKET SNAPSHOT
    • TABLE 45 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2018-2026 (USD MILLION)
    • TABLE 46 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 47 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 48 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 49 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 50 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
    • TABLE 51 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 High adoption rate of AEDs in the country to drive market growth
    • TABLE 52 US: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 53 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 54 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 55 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 High burden of CVDs in the country contributes to the growth of the defibrillators market in Canada
    • TABLE 56 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 57 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 58 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 59 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 60 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2018-2026 (USD MILLION)
    • TABLE 61 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 62 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 63 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 64 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 65 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
    • TABLE 66 EUROPE: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Presence of non-profit organizations that provide defibrillator services in the country to drive market growth in Germany
    • TABLE 67 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 68 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 69 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 70 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Rising support from government and private organizations and increasing awareness related to defibrillators are fueling market growth
    • TABLE 71 UK: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 72 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 73 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 74 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Increasing prevalence of chronic diseases in the geriatric population-a key driver for market growth in France
    • TABLE 75 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 76 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 77 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 78 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 High prevalence of OHCA in the country is driving the growth of the defibrillators market in Italy
    • TABLE 79 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 80 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 81 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 82 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing number of conferences and awareness programs to support the growth of the defibrillators market in Spain
    • TABLE 83 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 84 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 85 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 86 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 87 ROE: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 88 ROE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 89 ROE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 90 ROE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 24 ASIA PACIFIC: DEFIBRILLATORS MARKET SNAPSHOT
    • TABLE 91 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 2018-2026 (USD MILLION)
    • TABLE 92 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 93 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 94 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
    • TABLE 97 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Presence of a universal insurance scheme in Japan to support market growth
    • TABLE 98 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 99 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 100 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 101 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Growing focus of market players on expanding their presence in China to drive market growth
    • TABLE 102 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 103 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 104 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 105 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 High incidence and prevalence of CVDs in the country to drive market growth
    • TABLE 106 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 107 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 108 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 109 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 Measures taken by government and private bodies to make AEDs available at public sites in the country to drive market growth
    • TABLE 110 AUSTRALIA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 111 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 112 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 113 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.4.5 SOUTH KOREA
      • 9.4.5.1 Rising incidence of cardiac disorders to drive the growth of the defibrillators market in South Korea
    • TABLE 114 SOUTH KOREA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 115 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 116 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 117 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.4.6 REST OF ASIA PACIFIC (ROAPAC)
    • TABLE 118 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 119 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 120 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 121 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 122 LATIN AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2018-2026 (USD MILLION)
    • TABLE 123 LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 124 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 125 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 126 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 127 LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
    • TABLE 128 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
    • 9.5.1 BRAZIL
      • 9.5.1.1 Large obese population in the country results in an increased demand for defibrillators
    • TABLE 129 BRAZIL: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 130 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 131 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 132 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.5.2 MEXICO
      • 9.5.2.1 High prevalence of target diseases in the country to drive the growth of the defibrillators market in Mexico
    • TABLE 133 MEXICO: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 134 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 135 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 136 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • 9.5.3 REST OF LATIN AMERICA
    • TABLE 137 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 138 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 139 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 140 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • TABLE 141 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 142 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 143 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 144 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
    • TABLE 145 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
    • TABLE 146 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
    • FIGURE 25 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE DEFIBRILLATORS MARKET, 2018-2021
  • 10.2 REVENUE SHARE ANALYSIS
    • FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATORS MARKET
  • 10.3 MARKET SHARE ANALYSIS
    • FIGURE 27 DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2020
    • TABLE 147 DEFIBRILLATOR MARKET: DEGREE OF COMPETITION
  • 10.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020)
    • 10.4.1 TERMINOLOGY/NOMENCLATURE
      • 10.4.1.1 Stars
      • 10.4.1.2 Emerging leaders
      • 10.4.1.3 Pervasive players
      • 10.4.1.4 Participants
    • FIGURE 28 DEFIBRILLATORS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
  • 10.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (AS OF 2020)
    • 10.5.1 PROGRESSIVE COMPANIES
    • 10.5.2 RESPONSIVE COMPANIES
    • 10.5.3 DYNAMIC COMPANIES
    • 10.5.4 STARTING BLOCKS
    • FIGURE 29 DEFIBRILLATORS MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)
  • 10.6 COMPETITIVE BENCHMARKING
    • TABLE 148 PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATORS MARKET
    • TABLE 149 END-USER FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATOR MARKET
    • TABLE 150 COMPANY FOOTPRINT ANALYSIS IN THE DEFIBRILLATORS MARKET
  • 10.7 COMPETITIVE SCENARIO (2018-2021)
    • 10.7.1 NEW PRODUCT LAUNCHES & APPROVALS
    • 10.7.2 DEALS
    • 10.7.3 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business overview, Products offered, Recent developments, MNM view)**
    • 11.1.1 MEDTRONIC
    • TABLE 151 MEDTRONIC: BUSINESS OVERVIEW
    • FIGURE 30 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
    • 11.1.2 STRYKER CORPORATION
    • TABLE 152 STRYKER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 31 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.3 KONINKLIJKE PHILIPS N.V.
    • TABLE 153 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
    • FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
    • 11.1.4 ASAHI KASEI CORPORATION
    • TABLE 154 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
    • FIGURE 33 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.5 BOSTON SCIENTIFIC CORPORATION
    • TABLE 155 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
    • FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.6 ABBOTT
    • TABLE 156 ABBOTT: BUSINESS OVERVIEW
    • FIGURE 35 ABBOTT: COMPANY SNAPSHOT (2020)
    • 11.1.7 MICROPORT
    • TABLE 157 MICROPORT: BUSINESS OVERVIEW
    • FIGURE 36 MICROPORT: COMPANY SNAPSHOT (2020)
    • 11.1.8 NIHON KOHDEN CORPORATION
    • TABLE 158 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
    • FIGURE 37 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.9 BIOTRONIK
    • TABLE 159 BIOTRONIK: BUSINESS OVERVIEW
    • 11.1.10 CU MEDICAL SYSTEMS INC.
    • TABLE 160 CU MEDICAL SYSTEMS INC.: BUSINESS OVERVIEW
    • FIGURE 38 CU MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT (2020)
    • 11.1.11 METSIS MEDIKAL
    • TABLE 161 METSIS MEDIKAL: BUSINESS OVERVIEW
    • 11.1.12 MEDIANA CO. LTD.
    • TABLE 162 MEDIANA CO. LTD.: BUSINESS OVERVIEW
    • FIGURE 39 MEDIANA CO. LTD.: COMPANY SNAPSHOT (2020)
    • 11.1.13 MINDRAY MEDICAL INTERNATIONAL LIMITED
    • TABLE 163 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
    • FIGURE 40 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2020)
    • 11.1.14 PROGETTI SRL - MEDICAL EQUIPMENT SOLUTIONS
    • TABLE 164 PROGETTI SRL - MEDICAL EQUIPMENT SOLUTIONS: BUSINESS OVERVIEW
    • 11.1.15 SCHILLER AG
    • TABLE 165 SCHILLER AG: BUSINESS OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 BPL MEDICAL TECHNOLOGIES
    • TABLE 166 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
    • 11.2.2 METRAX GMBH (PRIMEDIC)
    • TABLE 167 METRAX GMBH (PRIMEDIC): BUSINESS OVERVIEW
    • 11.2.3 MS WESTFALIA GMBH
    • TABLE 168 MS WESTFALIA GMBH: BUSINESS OVERVIEW
    • 11.2.4 BEXEN CARDIO
    • TABLE 169 BEXEN CARDIO: BUSINESS OVERVIEW
    • 11.2.5 AXION MEDICAL EQUIPMENT LTD.
    • TABLE 170 AXION MEDICAL EQUIPMENT LTD.: BUSINESS OVERVIEW
    • 11.2.6 ELEMENT SCIENCE INC.
    • TABLE 171 ELEMENT SCIENCE INC.: BUSINESS OVERVIEW
    • 11.2.7 AVIVE SOLUTIONS INC.
    • TABLE 172 AVIVE SOLUTIONS INC.: BUSINESS OVERVIEW
    • 11.2.8 JEEVTRONICS PVT. LTD.
    • TABLE 173 JEEVTRONICS PVT. LTD.: BUSINESS OVERVIEW
    • 11.2.9 HEARTHERO INC.
    • TABLE 174 HEARTHERO INC.: BUSINESS OVERVIEW
    • 11.2.10 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.
    • TABLE 175 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: BUSINESS OVERVIEW
  • *Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS